Isolated central nervous system relapse in patient with blast-crisis chronic myeloid leukemia in durable complete cytogenetic remission on dasatinib treatment: pharmacokinetics and ABL mutation analysis in cerebrospinal fluid

被引：10
作者：
Zhou, Hong-Sheng [1 ,2 ]
Dai, Min [1 ,2 ]
Wei, Yongqiang [1 ,2 ]
Wang, Qiang [1 ,2 ]
Xu, Na [1 ,2 ]
Yin, Changxin [1 ,2 ]
Meng, Fanyi [1 ,2 ]
机构：
[1] Southern Med Univ, Nanfang Hosp, Dept Hematol, Guangzhou, Guangdong, Peoples R China
[2] Nanfang Hongkong Leukemia & Lymphoma Joint Res Ct, Guangzhou, Guangdong, Peoples R China
来源：
LEUKEMIA & LYMPHOMA | 2013年 / 54卷 / 07期
关键词：
ACUTE LYMPHOBLASTIC-LEUKEMIA; TYROSINE KINASE INHIBITOR; IMATINIB-RESISTANT; MESYLATE;
D O I：
10.3109/10428194.2012.745933
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1557 / 1559
页数：3
相关论文
共 13 条
  • [1] Isolated central nervous system relapse after nine years of complete molecular remission in a lymphoid blast crisis of chronic myeloid leukemia treated with imatinib
    Breccia, Massimo
    Santopietro, Michelina
    Cannella, Laura
    Federico, Vincenzo
    Loglisci, Giuseppina
    Serrao, Alessandra
    Petrucci, Luigi
    Salaroli, Adriano
    Nanni, Mauro
    De Propris, Maria Stefania
    Diverio, Daniela
    Alimena, Giuliana
    [J]. LEUKEMIA RESEARCH, 2011, 35 (06) : E91 - E92
  • [2] Discovery of 3-[2-(Imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide (AP24534), a Potent, Orally Active Pan-Inhibitor of Breakpoint Cluster Region-Abelson (BCR-ABL) Kinase Including the T315I Gatekeeper Mutant
    Huang, Wei-Sheng
    Metcalf, Chester A.
    Sundaramoorthi, Raji
    Wang, Yihan
    Zou, Dong
    Thomas, R. Mathew
    Zhu, Xiaotian
    Cai, Lisi
    Wen, David
    Liu, Shuangying
    Romero, Jan
    Qi, Jiwei
    Chen, Ingrid
    Banda, Geetha
    Lentini, Scott P.
    Das, Sasmita
    Xu, Qihong
    Keats, Jeff
    Wang, Frank
    Wardwell, Scott
    Ning, Yaoyu
    Snodgrass, Joseph T.
    Broudy, Marc I.
    Russian, Karin
    Zhou, Tianjun
    Commodore, Lois
    Narasimhan, Narayana I.
    Mohemmad, Qurish K.
    Iuliucci, John
    Rivera, Victor M.
    Dalgarno, David C.
    Sawyer, Tomi K.
    Clackson, Tim
    Shakespeare, William C.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (12) : 4701 - 4719
  • [3] Central nervous system is a sanctuary site for chronic myelogenous leukaemia treated with imatinib mesylate
    Isobe, Y.
    Sugimoto, K.
    Masuda, A.
    Hamano, Y.
    Oshimi, K.
    [J]. INTERNAL MEDICINE JOURNAL, 2009, 39 (06) : 408 - 411
  • [4] Central nervous system failure in patients with chronic myelogenous leukemia lymphoid blast crisis and Philadelphia chromosome positive acute lymphoblastic leukemia treated with Imatinib (STI-571)
    Leis, JF
    Stepan, DE
    Curtin, PT
    Ford, JM
    Peng, B
    Schubach, S
    Druker, BJ
    Maziarz, RT
    [J]. LEUKEMIA & LYMPHOMA, 2004, 45 (04) : 695 - 698
  • [5] Ponatinib is active against imatinib-resistant mutants of FIP1L1-PDGFRA and KIT, and against FGFR1-derived fusion kinases
    Lierman, E.
    Smits, S.
    Cools, J.
    Dewaele, B.
    Debiec-Rychter, M.
    Vandenberghe, P.
    [J]. LEUKEMIA, 2012, 26 (07) : 1693 - 1695
  • [6] Low concentrations of STI571 in the cerebrospinal fluid:: a case report
    Petzer, AL
    Gunsilius, E
    Hayes, M
    Stockhammer, G
    Duba, HC
    Schneller, F
    Grünewald, K
    Poewe, W
    Gastl, G
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (03) : 623 - 625
  • [7] Pfeifer H, 2003, CLIN CANCER RES, V9, P4674
  • [8] Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia
    Porkka, Kimmo
    Koskenvesa, Perttu
    Lundan, Tuija
    Rimpilaeinen, Johanna
    Mustjoki, Satu
    Smykla, Richard
    Wild, Robert
    Luo, Roger
    Arnan, Montserrat
    Brethon, Benoit
    Eccersley, Lydia
    Hjorth-Hansen, Henrik
    Hoeglund, Martin
    Klamova, Hana
    Knutsen, Havar
    Parikh, Suhag
    Raffoux, Emmanuel
    Gruber, Franz
    Brito-Babapulle, Finella
    Dombret, Herve
    Duarte, Rafael F.
    Elonen, Erkki
    Paquette, Ron
    Zwaan, C. Michel
    Lee, Francis Y. F.
    [J]. BLOOD, 2008, 112 (04) : 1005 - 1012
  • [9] First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia
    Ravandi, Farhad
    O'Brien, Susan
    Thomas, Deborah
    Faderl, Stefan
    Jones, Dan
    Garris, Rebecca
    Dara, Samuel
    Jorgensen, Jeffrey
    Kebriaei, Partow
    Champlin, Richard
    Borthakur, Gautam
    Burger, Jan
    Ferrajoli, Alessandra
    Garcia-Manero, Guillermo
    Wierda, William
    Cortes, Jorge
    Kantarjian, Hagop
    [J]. BLOOD, 2010, 116 (12) : 2070 - 2077
  • [10] Several types of mutations of the Abl gene can be found in chronic myeloid leukemia patients resistant to ST157, and they can pre-exist to the onset of treatment
    Roche-Lestienne, C
    Soenen-Cornu, V
    Grardel-Duflos, N
    Laï, JL
    Philippe, N
    Facon, T
    Fenaux, P
    Preudhomme, C
    [J]. BLOOD, 2002, 100 (03) : 1014 - 1018
12